Business angel syndicate ends year with appointment of IP expert to board Despite the challenges of the COVID-19 pandemic, Edinburgh-based business angel investment syndicate, Archangels, led investments of £16.3m in promising Scottish start-up and early stage companies in 2020, topping its 2019 total of £13.4m by 22%. Across 2020, the syndicate directly invested £8.1m (2019: £7.4m) in companies in the …
MGB Biopharma announces successful outcome from phase II clinical study on MGB-BP-3 for the treatment of Clostridium difficile infection
MGB Biopharma, the Glasgow-based biopharmaceutical company developing a novel class of anti-infectives, today announces the successful conclusion of its Phase II clinical study into MGB-BP-3, for the treatment of Clostridium difficile Infection (CDI). The study confirms that the drug has the potential to become the new gold standard, first-line treatment for CDI. CDI is a serious and often life-threatening infection of the large intestine …
Archangels leads further investment in home-grown Scottish innovators
Archangels, the Edinburgh-based business angel investment syndicate – believed to be the oldest in the world – has led investment of £6.2 million in Scottish early stage companies in the first quarter of 2020. Four tech and life sciences businesses – Blackford Analysis; Fios Genomics; Optoscribe; and Speech Graphics – were the recipients of the additional investment. £2.6 million came …
Scottish-based Optoscribe announces investment round from Archangels, Maven and Par Equity
Optoscribe Ltd, a world-leading supplier of 3D glass-based integrated photonics components, today announced that the company has closed its latest investment round. This funding round, which was led by Scottish business angel investment syndicate, Archangels, with participation from Maven Capital Partners, Par Equity and Scottish Investment Bank, will facilitate the continued expansion of the business and enable extended commercial engagement. …
Edinburgh-based CALCIVIS receives Approvable Letter from FDA
Edinburgh, March 5th 2020 – CALCIVIS, a medical devices company focused on modernising the management of tooth decay and enabling preventive dentistry, announces receipt of an Approvable Letter for the Premarket Approval (PMA) of its CALCIVIS® Imaging System from the US Food and Drug Administration (FDA). CALCIVIS intends to introduce this novel product in the US in 2021 with the …
Scottish cyber security firm ZoneFox acquired by Fortinet
Leading cyber security software specialist, ZoneFox, has been sold by its shareholders – including Scottish business angel investment syndicates, Archangels and TriCap, Scottish Investment Bank and Napier University – to US-based Fortinet.
Archangels & Maven back Optoscribe
Co-lead investment in Optoscribe from Archangels and Maven set to facilitate increase in manufacturing capacity and engineering resource, to meet customer demand.
New funds to fight C. difficile
MGB Biopharma’s anti-bacterial agent for treatment of C. difficile infections, helped by Archangels funding round, to enter Phase II clinical trials
Archangels Focuses on Scale-up
The role of Archangels in supporting Scottish companies to scale-up will be highlighted at the investment syndicate’s annual dinner, Chorus 2018.
Archangels and SIB back BDD
Archangels, SIB, & BDD complete a £2m funding round designed to enable BDD to scale its business, focusing on its precision timed drug delivery system.
Archangels supports healthcare platform
PhysioMedics, the Scottish early stage company that has developed a revolutionary online self-assessment platform…
Budget comment from Archangels
David Ovens, Chief Operating Officer at Archangels, the oldest & one of the largest business angel investment syndicates in the world, comments on budget
- Page 1 of 2